ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,428.63
-0.65%
S&P 500
5,650.20
0.34%
Dow Jones
40,796.73
1.45%
US Dollar vs Yen
158.551
0.26%
Brent Oil
83.405
-1.11%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) ニュース

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:OPRX
日付受信時刻ニュースソース見出しコード企業名
2021/04/1502 : 30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPRXOptimizeRx Corporation
2021/04/1405 : 15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/04/1320 : 51GlobeNewswire Inc.OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive YearNASDAQ:OPRXOptimizeRx Corporation
2021/04/0301 : 44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
2021/04/0301 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
2021/04/0301 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
2021/03/3005 : 16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OPRXOptimizeRx Corporation
2021/03/2222 : 25TipRanksOptimizeRX Will Continue To Thrive Post-PandemicNASDAQ:OPRXOptimizeRx Corporation
2021/03/1800 : 13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPRXOptimizeRx Corporation
2021/03/1705 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/03/1620 : 30GlobeNewswire Inc.OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021NASDAQ:OPRXOptimizeRx Corporation
2021/03/0321 : 31GlobeNewswire Inc.OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021NASDAQ:OPRXOptimizeRx Corporation
2021/02/2623 : 05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/02/2522 : 46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/02/2506 : 01GlobeNewswire Inc.OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per ShareNASDAQ:OPRXOptimizeRx Corporation
2021/02/2401 : 15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/02/2321 : 31GlobeNewswire Inc.OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 ListNASDAQ:OPRXOptimizeRx Corporation
2021/02/1906 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1903 : 06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1821 : 31GlobeNewswire Inc.OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ETNASDAQ:OPRXOptimizeRx Corporation
2021/02/1706 : 33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1621 : 31GlobeNewswire Inc.OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021NASDAQ:OPRXOptimizeRx Corporation
2021/02/1307 : 15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1206 : 52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1206 : 47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1205 : 24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1107 : 15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
2021/02/1106 : 44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPRXOptimizeRx Corporation
2021/02/0923 : 10GlobeNewswire Inc.OptimizeRx Announces Pricing of Public Offering of Common StockNASDAQ:OPRXOptimizeRx Corporation
2021/02/0907 : 22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX

最近閲覧した銘柄

AQSE
IDTL.GB
iShares USD Treasury Bon...
BIT
P20L23
NLBNPIT20L23 20991231 10...
BIT
F21426
Vontobel Financial Produ...
BIT
P1WN33
NLBNPIT1WN33 20991231 6....
BIT
NSCIT5410CA9
Italy
BIT
P1ZFU5
NLBNPIT1ZFU5 20241220 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有